Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity test, immunotoxicity test, safety pharmacology test, aquatic ecotoxicology test, histopathology/clinical pathology, and animal testing method. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.
Metrics to compare | 086040 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship086040PeersSector | |
---|---|---|---|---|
P/E Ratio | −7.1x | 10.7x | −0.5x | |
PEG Ratio | 0.22 | 0.16 | 0.00 | |
Price/Book | 1.1x | 1.2x | 2.6x | |
Price / LTM Sales | 1.1x | 2.8x | 3.0x | |
Upside (Analyst Target) | - | 35.4% | 54.7% | |
Fair Value Upside | Unlock | 7.8% | 8.4% | Unlock |